Transient ischemic attack (TIA) is a neglected condition and a marker of atherothrombotic disease. Several cohort studies have demonstrated that the risk of early cerebral infarct after TIA is much higher than previously thought. Many studies have shown that the risk of stroke is high after TIA, and is on average 4–6% in the first 2 days. Up to 23% of strokes are preceded by transient ischemic attack (TIA), and there is substantial research interest in improving prevention during the short window between TIA and stroke. Nonetheless, patients with TIA are often managed without urgency. The currently available evidence suggests that the application of clinical scales is useful for the detection of patients with high risk of recurrence, and this is increased significantly when the information from neuroimaging and Doppler assessments is added. However, the limited prognostic value of these clinical variables together with the elevated risk of suffering an adverse vascular event are driving the search for new predictive factors (biological markers, neuroimaging data, ultrasound) that will help towards a better discrimination of high-risk patients. Recent studies have demonstrated that prompt evaluation and treatment of patients with TIA in a dedicated outpatient unit is associated with a lower than expected risk of subsequent stroke.

1.
Acheson J, Hutchinson EC: Observations on the natural history of transient cerebral ischaemia. Lancet 1964;2:871–874.
2.
Fisher CM: Transient ischemic attacks. N Engl J Med 2002;347:1642–1643.
3.
Marshall J: The natural history of transient ischemic cerebrovascular attacks. Q J Med 1964;33:309–324.
4.
National Institute of Neurological Disorders and Stroke Ad Hoc Committee: Classification of Cerebrovascular Diseases III. Stroke 1990;21:637–676.
5.
Gass A, Ay H, Szabo K, Koroshetz WJ: Diffusion-weighted MRI for the ‘small stuff’: the details of acute cerebral ischaemia. Lancet Neurol 2004;3:39–45.
6.
Albers GW, Caplan LR, Easton JD, Fayad PB, Mohr JP, Saver JL, Sherman DG; TIA Working Group: Transient ischemic attack-proposal for a new definition. N Engl J Med 2002;347:1713–1716.
7.
Weisberg LA: Clinical characteristics of transient ischemic attacks in black patients. Neurology 1991;41:1410–1414.
8.
Levy DE: How transient are transient ischemic attacks? Neurology 1988;38:674–677.
9.
Kimura K, Minematsu K, Yasaka M, Wada K, Yamaguchi T: The duration of symptoms in transient ischemic attack. Neurology 1999;52:976–980.
10.
Feldmann E, Wilterdink J: The symptoms of transient cerebral ischemic attacks. Sem Neurol 1991;11:135–145.
11.
Brown RD, Evans BA, Wiebers DO, Petty GW, Meissner I, Dalle AJD: Transient ischemic attack and minor ischemic stroke: an algorithm for evaluation and treatment. Mayo Clin Proc 1994;69:1027–1039.
12.
Donnan GA, O’Malley HM, Quang L, Hurley S, Bladin PF: The capsular warning syndrome: pathogenesis and clinical features. Neurology 1993;43:957–962.
13.
Donnan GA, O’Malley HM, Quang L, Hurley S, Bladin PF: The capsular warning syndrome and lacunar transient ischaemic attacks; in Donnan GA, Norrving B, Bamford J, Bogousslavsky J (eds): Subcortical Stroke. London, Oxford University Press, 2002, pp 175–184.
14.
Bamford JM, Bogousslavski J: Lacunar and Other Subcortical Infarctions. New York, Oxford University Press, 1995, pp 47–55.
15.
Hankey GJ, Warlow CP: Lacunar transient ischaemic attacks: a clinically useful concept? Lancet 1991;337:335–338.
16.
Kappelle LJ, van Latum JC, Koudstaal PJ, van Gijn J; for the Dutch TIA Study Group: Transient ischaemic attacks and small-vessel disease. Lancet 1991;337:339–341.
17.
Marler JR, Tilley BC, Lu M, Brott TG, Lyden PC, Grotta JC, Broderick JP, Levine SR, Frankel MP, Horowitz SH, Haley EC Jr, Lewandowski CA, Kwiatkowski TP: Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology 2000;55:1649–1655.
18.
Sempere AP: Epidemiología de la enfermedad vascular cerebral; en Castillo J, Alvarez Sabín J, Martí-Vilalta J, Martínez-Vila E, Matías-Guiu J (eds): Manual de Enfermedades Vasculares Cerebrales, 2a Ed. Madrid, Prous Science, 1999, pp 55–62.
19.
Matías Guíu J, Oltra A, Falip R, Martín R, Galiano L: Occurrence of transient ischemic attacks in Alcoy: descriptive epidemiology. Neuroepidemiology 1994;13:34–39.
20.
López Pousa S, Villalta J, Llinás J: Incidencia de la enfermedad vascular cerebral en España: estudio en un área rural de Girona. Rev Neurol 1995;23:1074–1080.
21.
Sempere AP, Duarte J, Cabezas C, Clavería LE: Incidence of transient ischemic attacks and minor ischemic strokes in Segovia, Spain. Stroke 1996;27:667–671.
22.
Johnston SC: Clinical practice. Transient ischemic attack. N Engl J Med 2002;347:1687–1692.
23.
Ovbiagele B, Kidwell CS, Saver JL: Epidemiological impact in the United States of a tissue-based definition of transient ischemic attack. Stroke 2003;34:919–924.
24.
Love BB, Grover McKay M, Biller J, Rezay K, McKay CR: Coronary artery disease and cardiac events with asymptomatic and symptomatic cerebrovascular disease. Stroke 1992;23:939–945.
25.
Atanassova PA, Chalakova NT, Dimitrov BD: Major vascular events after transient ischaemic attack and minor ischaemic stroke: post hoc modelling of incidence dynamics. Cerebrovasc Dis 2008;25:225–233.
26.
Carolei A, Candelise L, Fiorelle M, et al: Long-term prognosis of transient ischemic attacks and reversible ischemic neurologic deficits: a hospital-based study. Cerebrovasc Dis 1992;2:266–272.
27.
Muuronen A, Kaste M: Outcome of 314 patients with transient ischemic attacks. Stroke 1982;13:24–31.
28.
Dennis M, Bamford J, Sandercock P, Warlow C: Prognosis of transient ischemic attacks in the Oxfordshire Community Stroke Project. Stroke 1990;21:848–853.
29.
Hankey GJ, Slattery JM, Warlow CP: The prognosis of hospital-referred transient ischemic attacks. J Neurol Neurosurg Psychiatry 1991;54:793–802.
30.
Heyman A, Wilkinson WE, Hurwitz BJ, et al: Risk of ischaemic heart disease in patients with TIA. Neurology 1984;34:626–630.
31.
Coull AJ, Lovett JK, Rothwell PM: Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. BMJ 2004;328:326–328.
32.
Johnston SC, Gress DR, Browner WS, Sidney S: Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000;284:2901–2906.
33.
Kleindorfer D, Panagos P, Pancioli A, et al: Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke 2005;36:720–723.
34.
Gladstone DJ, Kapral MK, Fang J, Laupacis A, Tu JV: Management and outcomes of transient ischemic attacks in Ontario. CMAJ 2004;170:1099–1104.
35.
Hill MD, Yiannakoulias N, Jeerakathil T, Tu JV, Svenson LW, Schopflocher DP: The high risk of stroke immediately after transient ischemic attack: a population-based study. Neurology 2004;62:2015–2020.
36.
Imray CH, Tiivas CA: Are some strokes preventable? The potential role of transcranial Doppler intransient ischaemic attacks of carotid origin. Lancet Neurology 2005;4:518–519.
37.
Rothwell PM, Warlow CP: Timing of TIAs preceding stroke: time window for prevention is very short. Neurology 2005;64:817–820.
38.
Tejada J, Maestre J, Larracoechea J, Gállego J: Guía para el tratamiento y prevención del ictus. 2001. Barcelona, Sociedad Española de Neurología, 2006.
39.
Clark TG, Murphy MF, Rothwell PM: Long term risks of stroke, myocardial infarction, and vascular death in ‘low risk’ patients with a non-recent transient ischaemic attack. J Neurol Neurosurg Psychiatry 2003;74:577–580.
40.
Dennis M, Bamford J, Sandercock P, Warlow C: Prognosis of transient ischemic attacks in the Oxfordshire Community Stroke Project. Stroke 1990;21:848–853.
41.
van Wijk I, Kappelle LJ, van Gijn J, Koudstaal PJ, Franke CL, Vermeulen M, Gorter JW, Algra A; LiLAC study group: Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study. Lancet 2005;365:2098–2104.
42.
Lovett JK, Dennis MS, Sandercock PA, Bamford J, Warlow CP, Rothwell PM: Very early risk of stroke after a first transient ischemic attack. Stroke 2003;34:138–142.
43.
Eliasziw M, Kennedy J, Hill MD, Buchan AM, Barnett HJ; North American Symptomatic Carotid Endarterectomy Trial Group: Early risk of stroke after a transient ischemic attack in patients with internal carotid artery disease. CMAJ 2004;170:1105–1109.
44.
Grotta JC, Welch KM, Fagan SC, Lu M, Frankel MR, Brott T, Levine SR, Lyden PD: Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial. Stroke 2001;32:661–668.
45.
Ovbiagele B, Cruz-Flores S, Lynn MJ, Chimowitz MI; Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group: Early stroke risk after transient ischemic attack. Arch Neurol 2008;65:733–737.
46.
Johston SC, Smith WS: Practice variability in management of transient ischemic attacks. Eur Neurol 1999;42:105–108.
47.
Johnston SC, Grees DR, Browner WS, Sidney S: Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000;284:2901–2906.
48.
Rothrock JF, Lyden PD, Yee J, Wiederholt WC: ‘Crescendo’ transient ischemic attacks: clinical and angiographic correlations. Neurology 1988;38:198–201.
49.
Eliasziw M, Streifler JY, Fox AJ, et al: Prognosis for patients following a transient ischemic attack with and without a cerebral infarction on brain CT. Neurology 1995;45:428–431.
50.
Kidwell CS, Warach S: Acute ischemic cerebrovascular syndrome: diagnostic criteria. Stroke 2003;34:2995–2998.
51.
Winbeck K, Bruckmaier K, Etgen T, von Einsiedel HG, Röttinger M, Sander D: Transient ischemic attack and stroke can be differentiated by analyzing early diffusion-weighted imaging signal intensity changes. Stroke 2004;35:1095–1099.
52.
Prabhakaran S, Chong JY, Sacco RL: Impact of abnormal diffusion-weighted imaging results on short-term outcome following transient ischemic attack. Arch Neurol 2007;64:1105–1109.
53.
Purroy F, Montaner J, Rovira A, Delgado P, Quintana M, Alvarez-Sabín J: Higher risk of further vascular events among transient ischemic attack patients with diffusion-weighted imaging acute ischemic lesions. Stroke 2004;35:2313–2319.
54.
Coutts SB, Simon JE, Eliasziw M, et al: Triaging transient ischemic attack and minor stroke patients using acute magnetic resonance imaging. Ann Neurol 2005;57:848–854.
55.
Giles MF, Rothwell PM: Prediction and prevention of stroke after transient ischemic attack in the short and long term. Expert Rev Neurother 2006;6:381–395.
56.
Hankey GJ: Long-term outcome after ischaemic stroke/transient ischaemic attack. Cerebrovasc Dis 2003;16(suppl 1):14–19.
57.
Panagos PD, Pancioli AM, Khoury J, et al: Short-term prognosis after emergency department diagnosis and evaluation of transient ischemic attack (TIA) (abstract). Acad Emerg Med 2003;10:432–433.
58.
Kennedy J, Hill MD, Eliasziw M, Buchan AM, Barnett HJ: Short-term prognosis following acute cerebral ischaemia. Stroke 2002;33:382–384.
59.
Purroy-García F, Montaner J, Delgado P, Ribó M, Arenillas-Lara JF, Quintana M, Álvarez-Sabín J: Factores clínicos predictores de la aparición de episodios vasculares tras un ataque isquémico transitorio. Rev Neurol 2004;38:416–421.
60.
Lisabeth LD, Ireland JK, Risser JM, et al: Stroke risk after transient ischemic attack in a population-based setting. Stroke 2004;35:1842–1846.
61.
Rothwell PM, Giles MF, Flossmann E, Lovelock CE, Redgrave JN, Warlow CP, Mehta Z: A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet 2005;366:29–36.
62.
Johnston SC, Rothwell PM, Nguyen-Huynh MN, Giles MF, Elkins JS, Bernstein AL, Sidney S: Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 2007;369:283–292.
63.
Tsivgoulis G, Spengos K, Manta P, Karandreas N, Zambelis T, Zakopoulos N, Vassilopoulos D: Validation of the ABCD score in identifying individuals at high early risk of stroke after a transient ischemic attack: a hospital-based case series study. Stroke 2006;37:2892–2897.
64.
Tsivgoulis G, Vassilopoulou S, Speng K: Potential applicability of ABCD2 score in triaging TIA patients. Lancet 2007;369:1082.
65.
Bray JE, Coughlan K, Bladin C: Can the ABCD score be dichotomised to identify high-risk patients with transient ischaemic attack in the emergency department? Emerg Med J 2007;24:92–95.
66.
Purroy F, Molina CA, Montaner J, Delgado P, Santamarina E, Toledo M, Quintana M, Alvarez Sabín J: Lack of usefulness of ABCD score in the early risk of recurrent stroke in transient ischemic attack patients. Med Clin (Barc) 2007;128:201–203.
67.
Cucchiara BL, Messe SR, Taylor RA, Pacelli J, Maus D, Shah Q, Kasner SE: Is the ABCD score useful for risk stratification of patients with acute transient ischemic attack? Stroke 2006;37:1710–1714.
68.
Koton S, Rothwell PM; for the Oxford Vascular Study: Performance of the ABCD and ABCD2 Scores in TIA patients with carotid stenosis and atrial fibrillation. Cerebrovasc Dis 2007;24:231–235.
69.
Sciolla R, Melis F; SINPAC Group: Rapid identification of high-risk transient ischemic attacks: prospective validation of the ABCD store. Stroke 2008;39:297–302.
70.
Rothwell PM, Giles MF, Chandratheva A, Marquardt L, Geraghty O, Redgrave JN, Lovelock CE, Binney LE, Bull LM, Cuthbertson FC, Welch SJ, Bosch S, Alexander FC, Silver LE, Gutnikov SA, Mehta Z; Early use of Existing Preventive Strategies for Stroke (EXPRESS) study group: Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet 2007;370:1432–1442.
71.
Lavallée PC, Meseguer E, Abboud H, Cabrejo L, Olivot JM, Simon O, Mazighi M, Nifle C, Niclot Lapergue B, Klein IF, Brochet E, Steg PG, Lesèche G, Labreuche J, Touboul PJ, Amarenco P: A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol 2007;6:940–941.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.